Patrick Harrington

460 total citations
28 papers, 168 citations indexed

About

Patrick Harrington is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Patrick Harrington has authored 28 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 19 papers in Hematology and 11 papers in Rheumatology. Recurrent topics in Patrick Harrington's work include Chronic Myeloid Leukemia Treatments (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Eosinophilic Disorders and Syndromes (11 papers). Patrick Harrington is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Eosinophilic Disorders and Syndromes (11 papers). Patrick Harrington collaborates with scholars based in United Kingdom, Italy and United States. Patrick Harrington's co-authors include Hugues de Lavallade, Claire Harrison, Deepti Radia, Natalia Curto‐García, Donal P. McLornan, Matteo Gadaleta, Shahram Kordasti, Steven R. Steinhubl, Evangelos Hytopoulos and Mintu P. Turakhia and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Patrick Harrington

26 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Harrington United Kingdom 8 70 67 30 29 28 28 168
Anna Waszczuk‐Gajda Poland 9 132 1.9× 61 0.9× 64 2.1× 26 0.9× 8 0.3× 51 230
Lisa Murray United States 7 96 1.4× 76 1.1× 19 0.6× 16 0.6× 37 1.3× 12 195
Natalia Curto‐García United Kingdom 9 116 1.7× 147 2.2× 37 1.2× 28 1.0× 77 2.8× 23 239
Clémence Mediavilla France 8 88 1.3× 31 0.5× 31 1.0× 10 0.3× 9 0.3× 18 137
Jennifer Davila United States 7 107 1.5× 63 0.9× 20 0.7× 42 1.4× 4 0.1× 21 178
Tara Cochrane Australia 7 56 0.8× 54 0.8× 52 1.7× 12 0.4× 5 0.2× 36 156
Monia Ouederni Tunisia 9 62 0.9× 62 0.9× 16 0.5× 18 0.6× 5 0.2× 29 204
George Chan New Zealand 7 79 1.1× 30 0.4× 47 1.6× 10 0.3× 18 0.6× 18 172
Chiara Quadrelli Italy 8 40 0.6× 22 0.3× 90 3.0× 31 1.1× 21 0.8× 13 174
Monica Maccaferri Italy 7 53 0.8× 76 1.1× 31 1.0× 21 0.7× 31 1.1× 17 160

Countries citing papers authored by Patrick Harrington

Since Specialization
Citations

This map shows the geographic impact of Patrick Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Harrington more than expected).

Fields of papers citing papers by Patrick Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Harrington. The network helps show where Patrick Harrington may publish in the future.

Co-authorship network of co-authors of Patrick Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Harrington. A scholar is included among the top collaborators of Patrick Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Harrington. Patrick Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duminuco, Andrea, Patrick Harrington, Vittorio Del Fabro, et al.. (2025). Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape. Pharmaceuticals. 18(8). 1212–1212. 1 indexed citations
2.
Duminuco, Andrea, Natalia Curto‐García, Priya Sriskandarajah, et al.. (2025). QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms. Leukemia. 39(10). 2384–2390. 4 indexed citations
3.
Chifotides, Helen T., Andrea Duminuco, Elena Torre, et al.. (2025). Emerging Therapeutic Approaches for Anemia in Myelofibrosis. Current Hematologic Malignancy Reports. 20(1). 7–7. 1 indexed citations
4.
Duminuco, Andrea, Joshua Au Yeung, Natalia Curto‐García, et al.. (2024). Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms. HemaSphere. 8(8). e143–e143. 7 indexed citations
5.
Gadaleta, Matteo, Patrick Harrington, Eric Barnhill, et al.. (2023). Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias. npj Digital Medicine. 6(1). 229–229. 32 indexed citations
6.
Harrington, Patrick, Richard Dillon, Deepti Radia, et al.. (2023). Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia. Haematologica. 108(6). 1555–1566. 3 indexed citations
7.
Duminuco, Andrea, Patrick Harrington, Claire Harrison, & Natalia Curto‐García. (2023). Polycythemia Vera: Barriers to and Strategies for Optimal Management. PubMed. Volume 13. 77–90. 7 indexed citations
8.
Harrington, Patrick, Richard Dillon, Deepti Radia, et al.. (2022). Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype. British Journal of Haematology. 198(6). 1011–1015. 8 indexed citations
9.
O’Sullivan, Jennifer, Deepti Radia, Natalia Curto‐García, et al.. (2022). Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys). Leukemia Research Reports. 19. 100360–100360. 12 indexed citations
10.
Harrington, Patrick, Hugues de Lavallade, Katie J. Doores, et al.. (2021). Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms. Leukemia. 35(12). 3573–3577. 31 indexed citations
11.
Harrington, Patrick, Claire Harrison, Richard Dillon, et al.. (2021). Evidence of robust memory T‐cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). British Journal of Haematology. 193(4). 692–696. 5 indexed citations
12.
Moonim, Mufaddal, Deepti Radia, Natalia Curto‐García, et al.. (2021). Clinicopathological characterisation of myeloproliferative neoplasm‐unclassifiable (MPN‐U): a retrospective analysis from a large UK tertiary referral centre. British Journal of Haematology. 193(4). 792–797. 7 indexed citations
13.
Harrington, Patrick, Richard Dillon, Deepti Radia, et al.. (2020). Inhibition of Immune Cell Subsets Is Differentially Affected By Dasatinib Dosage in Patients with Chronic Phase CML. Blood. 136(Supplement 1). 51–53. 2 indexed citations
14.
Harrington, Patrick, et al.. (2018). Ruxolitinib for the Treatment of Essential Thrombocythemia. HemaSphere. 2(4). e56–e56. 10 indexed citations
15.
Harrington, Patrick, et al.. (2018). Successful management of multiple pregnancies in a family with varying severity of Von Willebrand disease. Obstetric Medicine. 11(4). 192–194. 1 indexed citations
16.
Harrington, Patrick, Aytug Kizilors, & Hugues de Lavallade. (2017). The Role of Early Molecular Response in the Management of Chronic Phase CML. Current Hematologic Malignancy Reports. 12(2). 79–84. 11 indexed citations
17.
Harrington, Patrick, Catherine Nelson‐Piercy, Catherine Williamson, et al.. (2017). Refractory severe immune thrombocytopenia in a twin pregnancy. Obstetric Medicine. 11(1). 35–38. 10 indexed citations
18.
Harrington, Patrick. (2016). Optimization of Quantum Cellular Automata Majority Gate Using Multiobjective Reinforcement Learning. IOSR Journal of Computer Engineering. 18(4). 33–45.
19.
Harrington, Patrick & Tullie Yeghen. (2015). A new diagnosis of acute myeloid leukaemia complicated by peripancreatic tuberculous lymphadenitis. BMJ Case Reports. 2015. bcr2015209847–bcr2015209847. 1 indexed citations
20.
Harrington, Patrick, et al.. (2013). Acute presentation of rapidly progressive probable Creutzfeldt-Jakob disease. British Journal of Hospital Medicine. 74(3). 170–171.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Waszczuk‐Gajda Breakdown of academic impact, for papers by Lisa Murray Breakdown of academic impact, for papers by Natalia Curto‐García Breakdown of academic impact, for papers by Clémence Mediavilla Breakdown of academic impact, for papers by Jennifer Davila Breakdown of academic impact, for papers by Tara Cochrane Breakdown of academic impact, for papers by Monia Ouederni Breakdown of academic impact, for papers by George Chan Breakdown of academic impact, for papers by Chiara Quadrelli Breakdown of academic impact, for papers by Monica Maccaferri
Rankless by CCL
2026